The sera of 722 children and adolescents without overt liver disease were tested for hepatitis B surface antigen (HBsAg), antiHBs and anti-hepatitis B core anti-HBc; 658 of the sera were also tested for anti-hepatitis A virus anti-HAV. Except for the "passive" antibody peak observed in babies, the anti-HAV age-specific prevalence was negligible until the age of 3; it then increased, reaching 35% by the age of 15. Serological evidence of HBV was present in 16% of the subjects: this prevalence was almost constant at all ages. The HBsAg carrier rate was highest in children under 5 years of age (7.6%) and decreased with age. However, only one HBsAg carrier was under 1 year of age. Anti-HBs age-specific prevalence increased progressively from 2....
BACKGROUND: Compulsory vaccination of children against hepatitis B virus (HBV) infection was introdu...
the south and islands (83.3%) as compared to the north and central regions (45.2%). Social-demograph...
Objective. Evaluation of (1) coverage with three doses of hepatitis B vaccine in infants and adolesc...
The sera of 722 children and adolescents without overt liver disease were tested for hepatitis B sur...
During a multicentre study of chronic hepatitis in childhood diagnosed by biopsy, the spectrum of th...
Information regarding the current seroprevalence of hepatitis A virus (HAV) is useful for the contro...
Abstract Sera from 3160 subjects without overt liver disease were tested for the presence of HBsAg,...
We have studied by radioimmunoassay the prevalence of antibody to hepatitis A virus in 436 randomly ...
BACKGROUND: Compulsory vaccination of children against hepatitis B virus (HBV) infection was introdu...
During the period from January to May 1994, the prevalence of antibodies to hepatitis A virus infect...
During the period from January to May 1994, the prevalence of antibodies to hepatitis A virus infect...
blood was tested In 1981, regional prevalence of serologlc markers for hepatitis B was higher in sou...
BACKGROUND: Compulsory vaccination of children against hepatitis B virus (HBV) infection was introdu...
From 1983 to 1993 two anti-hepatitis B vaccinal strategies were adopted in two small towns of Southe...
The seroprevalence of anti-HCV antibody was studied among 2,749 children and teenagers (1,438 males ...
BACKGROUND: Compulsory vaccination of children against hepatitis B virus (HBV) infection was introdu...
the south and islands (83.3%) as compared to the north and central regions (45.2%). Social-demograph...
Objective. Evaluation of (1) coverage with three doses of hepatitis B vaccine in infants and adolesc...
The sera of 722 children and adolescents without overt liver disease were tested for hepatitis B sur...
During a multicentre study of chronic hepatitis in childhood diagnosed by biopsy, the spectrum of th...
Information regarding the current seroprevalence of hepatitis A virus (HAV) is useful for the contro...
Abstract Sera from 3160 subjects without overt liver disease were tested for the presence of HBsAg,...
We have studied by radioimmunoassay the prevalence of antibody to hepatitis A virus in 436 randomly ...
BACKGROUND: Compulsory vaccination of children against hepatitis B virus (HBV) infection was introdu...
During the period from January to May 1994, the prevalence of antibodies to hepatitis A virus infect...
During the period from January to May 1994, the prevalence of antibodies to hepatitis A virus infect...
blood was tested In 1981, regional prevalence of serologlc markers for hepatitis B was higher in sou...
BACKGROUND: Compulsory vaccination of children against hepatitis B virus (HBV) infection was introdu...
From 1983 to 1993 two anti-hepatitis B vaccinal strategies were adopted in two small towns of Southe...
The seroprevalence of anti-HCV antibody was studied among 2,749 children and teenagers (1,438 males ...
BACKGROUND: Compulsory vaccination of children against hepatitis B virus (HBV) infection was introdu...
the south and islands (83.3%) as compared to the north and central regions (45.2%). Social-demograph...
Objective. Evaluation of (1) coverage with three doses of hepatitis B vaccine in infants and adolesc...